Andrew William Fraser Brown
Andrew William Fraser Brown's purchase track record
Andrew William Fraser Brown has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/23/2022 | ZS | $544K | +2.9% | +31.2% | +13.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Zscaler Falls Steeper Than Broader Market Amid Cybersecurity Sector Weakness. Zscaler has fallen more steeply than the broader market recently. The decline follows a wider retreat in cybersecurity stocks after OpenAI acquisition reports. Analysts have re-rated Zscaler as a best value option, yet the stock sits near its 52-week low support level of $146.24. Price action continues to show downward pressure.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Guidewire Shares Rise as West Bend Expands AI Claims Platform. Guidewire Software shares climbed alongside other software peers, supported by news that West Bend is building an AI-driven claims foundation on the company's platform. This development highlights ongoing adoption of Guidewire's technology in insurance operations. The stock remains well below its 52-week high, with analysts maintaining a higher average price target.
Transaction History
| P | ▼ Sell | Open Market | 4,735 | $344K | 6/25/2026 | View on chart |
| P | ▲ Buy | Grant | 3,515 | $0 | 6/10/2026 | View on chart |
| P | ▼ Sell | Gift | 1,500 | $0 | 3/18/2026 | View on chart |
| P | ▼ Sell | Gift | 1,500 | $0 | 3/18/2026 | View on chart |
| P | ▼ Sell | Gift | 1,500 | $0 | 3/18/2026 | View on chart |
| P | ▼ Sell | Gift | 1,500 | $0 | 3/17/2026 | View on chart |
| ZS | ▲ Buy | Grant | 1,076 | $0 | 1/12/2026 | View on chart |
| ZS | ▼ Sell | Open Market | 5,000 | $0 | 12/26/2025 | View on chart |
| P | ▲ Buy | Grant | 4,735 | $0 | 6/11/2025 | View on chart |
| ZS | ▲ Buy | Option Exercise | 20,333 | $84K | 6/4/2025 | View on chart |
| ZS | ▼ Sell | Open Market | 392 | $116K | 6/4/2025 | View on chart |
| ZS | ▼ Sell | Open Market | 19,941 | $5.9M | 6/4/2025 | View on chart |
| ZS | ▲ Buy | Option Exercise | 10,000 | $41K | 4/2/2025 | View on chart |
| ZS | ▼ Sell | Open Market | 10,000 | $2.1M | 4/2/2025 | View on chart |
| ZS | ▲ Buy | Grant | 1,309 | $0 | 1/10/2025 | View on chart |
| ZS | ▲ Buy | Option Exercise | 8,000 | $33K | 9/23/2024 | View on chart |
| ZS | ▼ Sell | Open Market | 8,000 | $1.4M | 9/23/2024 | View on chart |
| P | ▲ Buy | Grant | 4,268 | $0 | 6/12/2024 | View on chart |
| P | ▼ Sell | Open Market | 20,564 | $1.1M | 4/15/2024 | View on chart |
| ZS | ▲ Buy | Grant | 976 | $0 | 1/5/2024 | View on chart |
| ZS | ▲ Buy | Option Exercise | 5,000 | $21K | 12/21/2023 | View on chart |
| ZS | ▼ Sell | Open Market | 5,000 | $1.1M | 12/21/2023 | View on chart |
| ZS | ▲ Buy | Option Exercise | 5,000 | $21K | 12/15/2023 | View on chart |
| ZS | ▼ Sell | Open Market | 5,000 | $1.1M | 12/15/2023 | View on chart |
| P | ▼ Sell | Open Market | 9,097 | $326K | 6/26/2023 | View on chart |
| P | ▲ Buy | Grant | 8,543 | $0 | 6/14/2023 | View on chart |
| ZS | ▲ Buy | Option Exercise | 3,846 | $16K | 6/9/2023 | View on chart |
| ZS | ▼ Sell | Open Market | 5,632 | $850K | 6/9/2023 | View on chart |
| ZS | ▲ Buy | Grant | 1,681 | $0 | 1/13/2023 | View on chart |
| ZS | ▲ Buy | Open Market | 5,000 | $544K | 12/23/2022 | View on chart |
| P | ▼ Sell | Open Market | 9,930 | $271K | 12/21/2022 | View on chart |
| P | ▼ Sell | Open Market | 12,637 | $381K | 9/12/2022 | View on chart |
| GWRE | ▼ Sell | Open Market | 4,000 | $297K | 6/23/2022 | View on chart |
| P | ▲ Buy | Grant | 9,097 | $0 | 6/15/2022 | View on chart |
| P | ▼ Sell | Open Market | 11,564 | $407K | 3/21/2022 | View on chart |
| ZS | ▲ Buy | Grant | 618 | $0 | 1/5/2022 | View on chart |
| GWRE | ▲ Buy | Grant | 1,691 | $0 | 12/14/2021 | View on chart |
| ZS | ▲ Buy | Option Exercise | 20,000 | $97K | 10/1/2021 | View on chart |
| ZS | ▼ Sell | Open Market | 19,800 | $5.2M | 10/1/2021 | View on chart |
| ZS | ▼ Sell | Open Market | 200 | $53K | 10/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Everpure Q2 revenues up 38%, shares fall on broader S&P 500 weakness
Everpure reported a 38% surge in Q2 revenues, prompting questions about whether this growth momentum can be sustained. Despite the strong top-line results, the stock fell alongside other S&P 500 names like RUM Group and Kyndryl during the recent trading session. The company's high valuation, reflected in a trailing P/E of 173.1, may make the stock sensitive to broader market sentiment and volatility.
Everpure Q2 revenues up 38%, shares fall on broader S&P 500 weakness. Everpure reported a 38% surge in Q2 revenues, prompting questions about whether this growth momentum can be sustained. Despite the strong top-line results, the stock fell alongside other S&P 500 names like RUM Group and Kyndryl during the recent trading session. The company's high valuation, reflected in a trailing P/E of 173.1, may make the stock sensitive to broader market sentiment and volatility.